Related references
Note: Only part of the references are listed.Biomarkers in oncology drug development
Darren R. Hodgson et al.
MOLECULAR ONCOLOGY (2009)
Targeted proteomic strategy for clinical biomarker discovery
Ralph Schiess et al.
MOLECULAR ONCOLOGY (2009)
The role of immunohistochemistry in the differential diagnosis of breast lesions
Takuya Moriya et al.
PATHOLOGY (2009)
Invasive apocrine carcinoma of the breast: Clinicopathologic features of 57 patients
Kimihiro Tanaka et al.
BREAST JOURNAL (2008)
What is triple-negative breast cancer?
William J. Irvin et al.
EUROPEAN JOURNAL OF CANCER (2008)
Biomarkers in oncology drug development: rescuers or troublemakers?
Estelle Marrer et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2008)
NSAIDs and breast cancer: a possible prevention and treatment strategy
A. Agrawal et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2008)
Refinement of breast cancer classification by molecular characterization of histological special types
B. Weigelt et al.
JOURNAL OF PATHOLOGY (2008)
15-Prostaglandin Dehydrogenase Expression Alone or in Combination with ACSM1 Defines a Subgroup of the Apocrine Molecular Subtype of Breast Carcinoma
Julio E. Celis et al.
MOLECULAR & CELLULAR PROTEOMICS (2008)
A single lysis solution for the analysis of tissue samples by different proteomic technologies
Pauel Gromov et al.
MOLECULAR ONCOLOGY (2008)
Biobanking for better healthcare
Peter H. J. Riegman et al.
MOLECULAR ONCOLOGY (2008)
Is 'basal-like' carcinoma of the breast a distinct clinicopathological entity? A critical review with cautionary notes
Farid Moinfar
PATHOBIOLOGY (2008)
A novel 3D in vitro culture model to study stromal-epithelial interactions in the mammary gland
Silva Krause et al.
TISSUE ENGINEERING PART C-METHODS (2008)
Clinical and pathologic aspects of basal-like breast cancers
Oluwole Fadare et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2008)
Statins and prostate cancer prevention:: where we are now, and future directions
Teemu J. Murtola et al.
NATURE CLINICAL PRACTICE UROLOGY (2008)
Triple negative tumours: a critical review
J. S. Reis-Filho et al.
HISTOPATHOLOGY (2008)
An update on apocrine lesions of the breast
F. P. O'Malley et al.
HISTOPATHOLOGY (2008)
The CD44(+)/CD24(-) phenotype is enriched in basal-like breast tumors
Gabriella Honeth et al.
BREAST CANCER RESEARCH (2008)
Non-operative breast pathology: apocrine lesions
C. A. Wells et al.
JOURNAL OF CLINICAL PATHOLOGY (2007)
Identification of a subset of breast carcinomas characterized by expression of cytokeratin 15: Relationship between CK15+progenitor/amplified cells and pre-malignant lesions and invasive disease
Julio E. Celis et al.
MOLECULAR ONCOLOGY (2007)
Targeting cell signaling pathways for drug discovery: An old lock needs a new key
Bharat B. Aggarwal et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
Vimentin and laminin expression is associated with basal-like phenotype in both sporadic and BRCA1-associated breast carcinomas
Socorro Maria Rodriguez-Pinilla et al.
JOURNAL OF CLINICAL PATHOLOGY (2007)
Cancer therapeutic antibodies come of age: Targeting minimal residual disease
Tsipi Ben-Kasus et al.
MOLECULAR ONCOLOGY (2007)
The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression
Paraic A. Kenny et al.
MOLECULAR ONCOLOGY (2007)
Characterization of breast precancerous lesions and myoepithelial hyperplasia in sclerosing adenosis with apocrine metaplasia
Julio E. Celis et al.
MOLECULAR ONCOLOGY (2007)
Three-dimensional culture models of normal and malignant breast epithelial cells
Genee Y. Lee et al.
NATURE METHODS (2007)
Identification of a basal-like subtype of breast ductal carcinoma in situ
Chad A. Livasy et al.
HUMAN PATHOLOGY (2007)
Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation
Marie-Liesse Asselin-Labat et al.
NATURE CELL BIOLOGY (2007)
Expression of oestrogen receptor-beta in apocrine carcinomas of the breast
N. Honma et al.
HISTOPATHOLOGY (2007)
Triple-negative breast cancer: therapeutic options
Susan Cleator et al.
LANCET ONCOLOGY (2007)
Cancer proteomics by quantitative shotgun proteomics
Emily I. Chen et al.
MOLECULAR ONCOLOGY (2007)
TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer
Anita Langerod et al.
BREAST CANCER RESEARCH (2007)
GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland
Hosein Kouros-Mehr et al.
CELL (2006)
Genomic and transcriptional aberrations linked to breast cancer pathophysiologies
Koei Chin et al.
CANCER CELL (2006)
Multivariate analysis of oestrogen receptor alpha, pS2, metallothionein and CD24 expression in invasive breast cancers
P. Surowiak et al.
BRITISH JOURNAL OF CANCER (2006)
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study
Lisa A. Carey et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Molecular pathology of breast apocrine carcinomas:: A protein expression signature specific for benign apocrine metaplasia
Julio E. Celis et al.
FEBS LETTERS (2006)
Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation
EA Rakha et al.
JOURNAL OF PATHOLOGY (2006)
Apocrine cysts of the breast -: Biomarkers, origin, enlargement, and relation with cancer phenotype
JE Celis et al.
MOLECULAR & CELLULAR PROTEOMICS (2006)
Frozen tissue biobanks. Tissue handling, cryopreservation, extraction, and use for proteomic analysis
Christer Ericsson et al.
ACTA ONCOLOGICA (2006)
Pharmaceuticals - A new grammar for drug discovery
MC Fishman et al.
NATURE (2005)
Regulation of prostaglandin metabolism by calcitriol attenuates growth stimulation in prostate cancer cells
J Moreno et al.
CANCER RESEARCH (2005)
Expression of GCDFP-15 and AR decreases in larger or node-positive apocrine carcinomas of the breast
N Honma et al.
HISTOPATHOLOGY (2005)
Identification of molecular apocrine breast tumours by microarray analysis
P Farmer et al.
ONCOGENE (2005)
Down-regulation of the tumor suppressor protein 14-3-3σ is a sporadic event in cancer of the breast
JMA Moreira et al.
MOLECULAR & CELLULAR PROTEOMICS (2005)
'Pure' invasive apocrine carcinoma of the breast: a new clinicopathological entity?
H Japaze et al.
BREAST (2005)
The role of CD24 in various human epithelial neoplasias
SC Lim et al.
PATHOLOGY RESEARCH AND PRACTICE (2005)
Cyclooxygenase-2: How good is it as a target for cancer chemoprevention?
MA Hull
EUROPEAN JOURNAL OF CANCER (2005)
The prognostic implication of the basal-like (cyclin Ehigh/p27low/p53+/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer
WD Foulkes et al.
CANCER RESEARCH (2004)
Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma
TO Nielsen et al.
CLINICAL CANCER RESEARCH (2004)
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
S Paik et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Repeated observation of breast tumor subtypes in independent gene expression data sets
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Special types of invasive breast cancer, with clinical implications
DL Page
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2003)
Mass spectrometry-based proteomics
R Aebersold et al.
NATURE (2003)
CD24 is an independent prognostic marker of survival in nonsmall cell lung cancer patients
G Kristiansen et al.
BRITISH JOURNAL OF CANCER (2003)
A gene-expression signature as a predictor of survival in breast cancer.
MJ van de Vijver et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Inhibition of NAD+-dependent 15m-hydroxyprostagland in dehydrogenase (15-PGDH) by cyclooxygenase inhibitors and chemopreventive agents
H Cho et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2002)
Cyclooxygenase-2 is overexpressed in HER-2/neu-positive breast cancer - Evidence for involvement of AP-1 and PEA3
K Subbaramaiah et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Gene expression profiling predicts clinical outcome of breast cancer
LJ van't Veer et al.
NATURE (2002)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
Share Paper
